The Aging Male · 2022 · 18 citations · 32 references
MedicineEndocrinologyMass Spectrometric AnalysisReproductive EndocrinologyReproductive MedicineGonadal EndocrinologyGonadal HormonesGonadal Steroid HormonesHormonal EvaluationHypothalamic-pituitary-gonadal AxisMale Reproductive EndocrinologyFree Testosterone AssessmentGonadal Hormone AssaysHypothalamic-pituitary-gonadal Axis DysfunctionLiquid Chromatography-mass SpectrometryPrimary HypogonadismSerum Testosterone MeasurementSex Hormone-binding GlobulinSex Steroid Measurement
BACKGROUND: Data about classification of hypogonadism and estrogen deficiency in male people living with HIV (PLWH) are scanty. AIM: To investigate the prevalence and characterization of biochemical hypogonadism and relative estrogen deficiency in male PLWH aged < 50 comparing liquid chromatography-tandem mass spectrometry (LC-MS/MS) with chemiluminescent immunoassay (CI), and combining gonadotropin, sex hormone-binding globulin (SHBG) and serum estradiol (E2) measurements. METHODS: Prospective, cross-sectional, observational study. Serum total testosterone (TT), E2, gonadotropins, SHBG were measured by CI. TT and E2 were also assessed by LC-MS/MS. Free testosterone (cFT) was calculated by Vermeulen equation. RESULTS: < 0.0001). The prevalence of hypogonadism (overt + compensated) was 17.1% for cFT using LC-MS/MS. Secondary form of hypogonadism was more prevalent than primary. The prevalence of relative estrogen deficiency was of 30.0% among hypogonadal patients and 15.5% among eugonadal. CONCLUSIONS: The prevalence of male hypogonadism results underestimated by CI compared to LC-MS/MS in PLWH, both for TT and cFT. SHBG and gonadotropins are essential for detecting T deficiency.
32